Hongfeng Gou, Li Zheng, Xiuying Xiao, Liwei Wang, Hongli Li, Jieer Ying, Yueyin Pan, Shuqin Ni, Zuoxing Niu, Jun Zhang, Ling Lu, Xiaoyan Lin, Wei He, Wenlong Zhai, Wenhui Yang, Bin Bai, Pingan Yao, Han Cui, Jiankun Hu. "A phase 1 study of SHR-3821, an ADCC-enhanced CLDN18.2/4-1BB bispecific antibody, in patients with advanced solid tumors.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4037